Herbert A Fritsche
Overview
Explore the profile of Herbert A Fritsche including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
1251
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fritsche H, Bullock R
Int J Gynaecol Obstet
. 2023 Feb;
162(2):485-492.
PMID: 36820488
Objectives: Patients with adnexal masses suspicious for malignancy benefit from referral to oncology specialists during presurgical assessment of the mass. OVA1 is a multivariate assay using a five-biomarker panel which...
2.
Palmieri V, Dodds W, Morgan J, Carney E, Fritsche H, Jeffrey J, et al.
Vet Med Sci
. 2020 Jun;
6(4):933-945.
PMID: 32485788
A veterinarian and pet owner survey (Project Jake) examined the use and safety of isoxazoline parasiticides given to dogs. Data were received during August 1-31, 2018 from a total of...
3.
Overholt B, Wheeler D, Jordan T, Fritsche H
Gastrointest Endosc
. 2016 Sep;
84(4):754.
PMID: 27633369
No abstract available.
4.
Albitar M, Ma W, Lund L, Albitar F, Diep K, Fritsche H, et al.
J Cancer
. 2016 Feb;
7(3):297-303.
PMID: 26918043
Background: Determining the need for prostate biopsy is frequently difficult and more objective criteria are needed to predict the presence of high grade prostate cancer (PCa). To reduce the rate...
5.
Overholt B, Wheeler D, Jordan T, Fritsche H
Gastrointest Endosc
. 2015 Aug;
83(3):545-51.
PMID: 26318832
Background And Aim: Colorectal cancer (CRC) remains the second most frequent cause of cancer deaths in the United States. Blood tests using tumor-related antigens aid in diagnosing CRC. However, higher...
6.
Ma W, Diep K, Fritsche H, Shore N, Albitar M
Genet Test Mol Biomarkers
. 2014 Feb;
18(3):156-63.
PMID: 24512523
Aims: To avoid relying solely on serum prostate-specific antigen (sPSA) in screening for prostate cancer (PCa), we developed a scoring system for detecting PCa and the prediction of aggressiveness. We...
7.
Konoplev S, Fritsche H, OBrien S, Wierda W, Keating M, Gornet T, et al.
Am J Clin Pathol
. 2010 Aug;
134(3):472-7.
PMID: 20716805
Serum thymidine kinase 1 (TK1) levels have been reported to have prognostic significance in patients with chronic lymphocytic leukemia (CLL). Until recently, serum TK1 levels were assessed using inconvenient radioenzyme...
8.
Sturgeon C, Duffy M, Hofmann B, Lamerz R, Fritsche H, Gaarenstroom K, et al.
Clin Chem
. 2010 Mar;
56(6):e1-48.
PMID: 20207771
Background: Updated National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for the use of tumor markers in the clinic have been developed. Methods: Published reports relevant to use of...
9.
De Giorgi U, Valero V, Rohren E, Dawood S, Ueno N, Miller M, et al.
J Clin Oncol
. 2009 May;
27(20):3303-11.
PMID: 19451443
Purpose: Circulating tumor cells (CTCs) and [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) are two new promising tools for therapeutic monitoring. In this study, we compared the prognostic value...
10.
Grote T, Siwak D, Fritsche H, Joy C, Mills G, Simeone D, et al.
Proteomics
. 2008 Jul;
8(15):3051-60.
PMID: 18615426
The current study analyzed reverse phase protein arrays (RPPA) as a means to experimentally validate biomarkers in blood samples. One microliter samples of sera (n = 71), and plasma (n...